Literature DB >> 9857883

Comparative prognostic value of automatic quantitative analysis versus semiquantitative visual analysis of exercise myocardial perfusion single-photon emission computed tomography.

D S Berman1, X Kang, K F Van Train, H C Lewin, I Cohen, J Areeda, J D Friedman, G Germano, L J Shaw, R Hachamovitch.   

Abstract

OBJECTIVES: The purpose of this study was to determine the prognostic value of automatic quantitative analysis in exercise dual-isotope myocardial perfusion single-photon emission computed tomography (SPECT) and to compare the prognostic value of quantitative analysis to semiquantitative visual SPECT analysis.
BACKGROUND: Extent, severity and reversibility of exercise myocardial perfusion defects have been shown to correlate with prognosis. However, most studies examining the prognostic value of SPECT in chronic coronary artery disease (CAD) have been based on visual analysis by experts.
METHODS: We studied 1,043 consecutive patients with known or suspected CAD who underwent rest Tl-201/exercise Tc-99m sestamibi dual-isotope myocardial perfusion SPECT and were followed up for at least 1 year (mean 20.0+/-3.7 months). After censoring 59 patients with early coronary artery bypass grafting or percutaneous transluminal coronary angioplasty, <60 days after nuclear testing, the final population consisted of 984 patients (36% women, mean age 63+/-12 years).
RESULTS: During the follow-up period, 28 hard events (14 cardiac deaths, 14 nonfatal myocardial infarctions) occurred. Patients with higher defect extent (>10%), severity (>150) and reversibility (>5%) by quantitative SPECT defect analysis, as well as those with an abnormal scan (>2 abnormal segments, summed stress score >4 and summed difference score >2) by semiquantitative visual SPECT analysis, had a significantly higher hard event rate compared to patients with a normal scan (p < 0.001). With both visual and quantitative analyses, hard event rates of approximately 1% with normal scans and 5% with abnormal scans (p > 0.05) were observed over the 20-month follow-up period. A Cox proportional hazards regression model showed that chi-square increased similarly with the addition of quantitative defect extent and visual summed stress score variables after considering both clinical and exercise variables (improvement chi-square = 11 for both, p < 0.0007). There were no significant differences in the areas under receiver operating characteristic curves between quantitative and visual analysis (p > 0.70). Linear regression analysis also indicated that quantitative assessments correlated well with visual semiquantitative assessments.
CONCLUSIONS: The findings of this study indicate that automatic quantitative analysis of exercise stress myocardial perfusion SPECT is similar to semiquantitative expert visual analysis for prognostic stratification. These findings may be of particular clinical importance in laboratories with less experienced visual interpreters.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9857883     DOI: 10.1016/s0735-1097(98)00501-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  42 in total

Review 1.  Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiologic, and clinical issues.

Authors:  P Kailasnath; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

Review 2.  Quantification of SPECT myocardial perfusion imaging.

Authors:  Wanda Acampa; Wei He; Carmine di Nuzzo; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

3.  Lake Tahoe invitation meeting 2002.

Authors: 
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

4.  EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology.

Authors:  B Hesse; K Tägil; A Cuocolo; C Anagnostopoulos; M Bardiés; J Bax; F Bengel; E Busemann Sokole; G Davies; M Dondi; L Edenbrandt; P Franken; A Kjaer; J Knuuti; M Lassmann; M Ljungberg; C Marcassa; P Y Marie; F McKiddie; M O'Connor; E Prvulovich; R Underwood; B van Eck-Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

5.  Depressed heart rate response to vasodilator stress for myocardial SPECT predicts mortality in patients after myocardial infarction.

Authors:  Young Hwan Kim; Kyung-Han Lee; Hong Joo Chang; Eun Jeong Lee; Hyun Woo Chung; Joon Young Choi; Yong Choi; Yearn Seong Choe; Sang Hoon Lee; Byung-Tae Kim
Journal:  Int J Cardiovasc Imaging       Date:  2006-04-21       Impact factor: 2.357

6.  Prognostic value of gated SPECT in patients with left bundle branch block.

Authors:  Yves G C J America; Jeroen J Bax; Eric Boersma; Marcel Stokkel; Ernst E van der Wall
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

7.  Evaluation of a decision support system for interpretation of myocardial perfusion gated SPECT.

Authors:  Milan Lomsky; Peter Gjertsson; Lena Johansson; Jens Richter; Mattias Ohlsson; Deborah Tout; Andries van Aswegen; S Richard Underwood; Lars Edenbrandt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03-04       Impact factor: 9.236

8.  Incremental prognostic value of combined perfusion and function assessment during myocardial gated SPECT in patients aged 75 years or older.

Authors:  Olivier De Winter; Anja Velghe; Nico Van de Veire; Pieter De Bondt; Marc De Buyzere; Christophe Van De Wiele; Guy De Backer; Thierry C Gillebert; Rudi A Dierckx; Johan De Sutter
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

Review 9.  Quantitative Clinical Nuclear Cardiology, Part 1: Established Applications.

Authors:  Ernest V Garcia; Piotr Slomka; Jonathan B Moody; Guido Germano; Edward P Ficaro
Journal:  J Nucl Med       Date:  2019-11       Impact factor: 10.057

10.  Prognostic value of quantitative high-speed myocardial perfusion imaging.

Authors:  Ryo Nakazato; Daniel S Berman; Heidi Gransar; Mark Hyun; Romalisa Miranda-Peats; Faith C Kite; Sean W Hayes; Louise E J Thomson; John D Friedman; Alan Rozanski; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2012-10-12       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.